About me
Christopher Roselle is the Director of Strategy & Operations at Recursion, where he works
across the company’s platform and pipeline on portfolio and operational strategy.
Prior to joining Recursion, Chris worked at Boston Consulting Group, advising
biopharmaceutical companies on AI adoption, R&D, and corporate strategy. He holds a PhD in
Systems Pharmacology and Translational Therapeutics from the University of Pennsylvania,
where his research focused on CAR T cell therapy in the laboratory of Dr. Carl June. He began
his career at Merck, spending eight years in roles spanning vaccine manufacturing and
development.
At Recursion, Chris draws on his experience across academic research, industry R&D, and
management consulting to understand the strategic and competitive dynamics shaping
AI-enabled drug discover
